Detalles de la búsqueda
1.
QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
Thorax;
2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050168
2.
The increasing burden of asthma acute care in Singapore: an update on 15-year population-level evidence.
BMC Pulm Med;
23(1): 502, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087287
3.
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled ß2-agonists in patients with asthma, COPD or asthma-COPD overlap.
Respir Res;
23(1): 364, 2022 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539784
4.
Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis.
J Asthma;
58(3): 344-359, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31668101
5.
A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk.
Eur Respir J;
62(2)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37652564
6.
Association between Inhaled ß2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.
Int J Chron Obstruct Pulmon Dis;
17: 1205-1217, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35645559
7.
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study.
Int J Chron Obstruct Pulmon Dis;
15: 2355-2366, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33061353
8.
Validated methods to identify patients with asthma-COPD overlap in healthcare databases: a systematic review protocol.
BMJ Open;
9(3): e024306, 2019 03 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30872543
Resultados
1 -
8
de 8
1
Próxima >
>>